The Respiratory Medicine symposium considered many topics including the difficulties of managing functional breathlessness and breathlessness in pregnancy, pigeon fancier's lung, interventional bronchoscopy, inhalation therapy for COPD, pulmonary rehabilitation, and terminal care in non-malignant respiratory disease. The Robert W Philip Memorial Lecture focused on advances in the acute respiratory distress syndrome.
Get full access to this article
View all access options for this article.
References
1.
Symposium abstracts: Respiratory Medicine 2003. J R Coll Physicians Edinb 2004; 34(2): 137-43.
2.
AshbaughDGDBBigelowTLPettyLevineBE.Acute Respiratory distress in adults. Lancet 1967; 2(7511):319-23.
3.
BernardGRAArtigasBrighamKL The American-European consensus conference on ARDS. Definitions,mechanisms,relevant outcomes, and clinical trial co-ordination. Am J Respir Crit Care Med 1994; 149(3 pt 1):818-24.
GattinoniLPPelosiPMSuterAPedotoPVercesiLissoniA.Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease:different syndromes?Am J Respir Crit Care Med1998; 158:3-11.
6.
DonnellySCRMStrieterKunkelSL Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993; 341(8846):643-7.
7.
JanssenRHSatoGruttersJC Study of clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis. Chest 2003; l24(6):2II9-25.
8.
SatoHMECallisterMumbyS KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome. Eur Respir J 2004; 23(1): 142-5.
9.
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Eng J Med 2000; 342: 1301-8.
10.
Gattinoni L,Tognoni G, Pesent A Effect of prone positioning on the survival of patients with acute respiratory failure. N Eng J Med2001; 345:568-73.
11.
LewandowskiK.Extracorporeal membrane oxygenation for severe acute respiratory failure. Crit Care 2000; 4(3): 156-68.
12.
GadekJESJDeMicheleKarlstadMD Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral nutrition in ARDS study group. Crit Care Med I999; 27(8): I409-20.
13.
LewisJFBrackenburyA. Role of exogenous surfactant in acute lung injury. Crit Care Med 2003; 3l(4 Suppl):S324-8.
14.
ThompsonBT.Glucocorticoids and acute lung injury. Crit Care Med 2003; 31(4Suppl):S253-7.
15.
Reid S, Wessely S, Crayford T Medically unexplained symptoms in frequent attenders of secondary health care: retrospective cohort study. BMJ 2001; 322(7289):767
16.
DePasoWJRHWinterbauerLuskJA Chronic dyspnoea unexplained by history, physical examination, chest roentgenogram, and spirometry. Analysis of a seven year experience. Chest I99I; l00(5): I293-9.
17.
PottsSGRLewinFoxKA Group psychological treatment for chest pain with normal coronary arteries. QJM 1999; 92(2):81-6.
18.
CrapoRO.Normal cardiopulmonary physiology during pregnancy. Clin Obstet Gynecol 1996; 39(1):3-16.
19.
ChanWSJGRayMurrayS Suspected pulmonary embolism in pregnancy: clinical presentation, results of lung scanning, and subsequent maternal and pediatric outcomes. Arch Intern Med 2002; 162(10): 1170-5.
20.
Chen J, Lee RJ,Tsodikov A Does radiotherapy around the time of pregnancy for Hodgkin’s disease modify the risk of breast cancer? Int J Radiat Oncol Biol Phys 2004; 58(5): 1474-9.
21.
Drife J. Thromboembolism. Br Med Bull 2003; 67: 177-90.
22.
Bates SM. Optimal management of pregnant women with acute venous thromboembolism. Haemostasis 1999; 29(Suppl S1): 107-11.
23.
GreerIA.Prevention and management of venous thromboembolism in pregnancy. Clin Chest Med 2003; 24(1): 123-37.
24.
Kaiser UB. The pathogenesis of the ovarian hyperstimulation syndrome. N Eng J Med 2003; 349(8):729-32.
Nelson-Piercy C. Asthma in pregnancy. Thorax2001; 56:325-8.
27.
Cydulka RK, Emerman CL, Schreiber D Acute asthma among pregnant women presenting to the emergency department. Am J Respir Crit Care Med 1999; 160(3):887-92.
28.
Ie S, Rubio ER, Alper B Respiratory complications of pregnancy. Obstet Gynecol Surv 2002; 57(1):39—46.
29.
Edenborough FP. Women with cystic fibrosis and their potential for reproduction. Thorax2001; 56:649-55.
30.
Kotloff RM, FitzSimmons SC, Fiel SB. Fertility and pregnancy in patients with cystic fibrosis. Clin Chest Med I992; l3:623-35.
Selman M, Teran L, Mendoza A Increase of HLA-DR7 in pigeon breeder’s lung in a Mexican population. Clin Immunol Immunopathol 1987; 44(1):63-70.
37.
Rittner C, Sennakamp J, Vogel F Letter: HLA-B8 in pigeon-fancier’s lung. Lancet 1975;2(7948):1303.
38.
Anderson K, Morrison S, Bourke S Effect of cigarette smoking on the specific antibody response in pigeon fanciers. Thorax I988; 43:798-800.
39.
Editorial. Pigeon Racing News and Gazette. October I975.
40.
BarberPStoutR. High dose rate endobronchial brachytherapy for the treatment of lung cancer: Current status and indications. Thorax I996; 5l:345-7.
41.
Barber P, Barr H, George J Photodynamic therapy in the treatment of lung and oesophageal cancers. Clinic Oncol 2002; 14(2): 110-16.
42.
RabenAMychalczakB. Brachytherapy for non-small cell lung cancer and selected neoplasms of the chest. Chest I997; ll2(4 Suppl):276S-286S.
43.
LorchelFDSpaethScheidP High dose rate brachytherapy: a potentially curative treatment for small invasive TIN0 endobronchial carcinoma and carcinoma in situ. Rev Mal Respir 2003; 20(4):515-20.
44.
Moghissi K, Dixon K. Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer? Eur Respir J 2003; 22:535—41.
COMBIVENT Inhalation Aerosol Study Group. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. Chest 1994; 105(5): 1411-19.
47.
CalverleyPMALeeTowseL Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Thorax 2003; 58(l0):855-60.
48.
Vincken W, Van Noord JA, Gleefhorst AP Improved health outcomes in patients with COPD during I yr’s treatment with tiotropium Eur Respir J 2002; 19(2):209-16.
49.
Pauwels RA, Lofdahl CG, Laitinen LA Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on chronic obstructive pulmonary disease. N Eng J Med 1999; 340:1948.
50.
Burge PS, Calverley PM, Jones PW Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial BMJ 2000; 320(7245): 1297-303.
51.
JonesPWLRWillitsBurgePS Inhaled steroids in obstructive lung disease in Europe study investigators. Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations. Eur Respir J 2003; 21(1):68-73.
52.
MahlerDAPWireHorstmanD Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease Am J Respir Crit Care Med 2002; 166(8): 1084-9.
53.
Pulmonary Rehabilitation-I999. American Thoracic Society. Am J Respir Crit Care Med 1999; 159(5 pt 1): 1666-82.
54.
Lacasse Y, Wong E, Guyatt GH Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996; 348(9035): 1115-9.
55.
GriffithsTLMLBurrCampbellIA Results at I year of outpatient multidisciplinary pulmonary rehabilitation: a randomized controlled trial. Lancet 2000; 355(920l):362-8.
56.
LacasseYGHGuyattGoldsteinRS The components of a respiratory rehabilitation programme: a systematic overview. Chest 1997; 111(4): 1077-88.
57.
RiesALRMKaplanMyersR Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. Am J Respir Crit Care Med 2003; 167(6):880-88.
58.
FoglioKLBianchiAmbrosinoN Is it really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airway obstruction? A 2 year controlled study. Chest 2001; 119(6): 1696-704.
59.
Hernandez MT, Rubio TM, Ruiz FO Results of a home based training program for patients with COPD. Chest 2000; 118(1): 106-14.
60.
StrijbosJHDSPostmaVan AltenaR Feasibility and effects of a home care rehabilitation program in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 1996; 16(6):386-93.
61.
JonesRCSCopperRileyO A pilot study of pulmonary rehabilitation in primary care. Br J Gen Pract 2002; 52(480):567-8 Griffiths TL, Phillips CJ, Davies S Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax 200I; 56(l0):779-84.
62.
EdmondsP.A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med 200I; l5(4):287-95.
63.
Gore JM, Brophy CJ and Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 2000; 55(12): 1000-6.
64.
Katsura H. End of life care for patients with COPD. Nippon Rinsho 2003; 61(12):2212-9.
65.
Skilbeck J, Small N, Ahmedzai SH. Nurses’ perception of specialist palliative care in an acute hospital. Int J Palliative Nursing 1999; 5: 110-15.
66.
Gott MC, Ahmedzai SH, Wood C. How many inpatients at an acute hospital have palliative care needs? Comparing the perspectives of medical and nursing staff. Palliat Med 2001; 15(6):451-60.
67.
Ahmedzai SH and Walsh D. Palliative medicine and modern cancer care. Semin Oncol 2000; 27(1):1-6.
